| Yulia Khan, MD | |
|
740 E Highland Ave Ste 101, Phoenix, AZ 85014-3609 | |
| (602) 264-9044 | |
| Not Available |
| Full Name | Yulia Khan |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 16 Years |
| Location | 740 E Highland Ave Ste 101, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386808368 | NPI | - | NPPES |
| P00937246 | Other | MN | RAILROAD MEDICARE |
| ENROLLED | Medicaid | IA | |
| ENROLLED | Medicaid | MN |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Dermatology Of Arizona Pc | 0547561169 | 13 |
News Archive
Accuray Incorporated announced today that studies on the clinical use of the TomoTherapy System continue to demonstrate its mainstream use and the benefits of its gold-standard treatment planning and delivery capabilities. More than 30 studies were presented during poster or oral sessions at the 57th Annual Meeting of the American Association of Physicists in Medicine held in Anaheim, California July 12 – July 16, 2015.
This week the World Health Organization released its newly updated 4th WHO Model List of Essential Medicines for Children, in which three treatments developed by the Drugs for Neglected Diseases initiative and its partners have now been included.
A new study by researchers at NYU Langone Medical Center and colleagues found that traditional risk factors for stroke - such as high cholesterol - are not as accurate at predicting risk in postmenopausal women as previously thought. Instead, researchers say doctors should refocus their attention on triglyceride levels to determine which women are at highest risk of suffering a devastating and potentially fatal cardiovascular event.
Anadys Pharmaceuticals, Inc. announced today the pricing of its underwritten public offering of 13,888,889 shares of its common stock at a price to the public of $1.80 per share. The gross proceeds to Anadys from this offering are expected to be approximately $25.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses.
Approval by the Obama administration was expected after it gave its initial go-ahead just hours before Florida Gov. Rick Scott announced his support for the health law's Medicaid expansion.
› Verified 1 days ago
| Entity Name | Advanced Dermatology Of Arizona Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922484088 PECOS PAC ID: 0547561169 Enrollment ID: O20151223000796 |
News Archive
Accuray Incorporated announced today that studies on the clinical use of the TomoTherapy System continue to demonstrate its mainstream use and the benefits of its gold-standard treatment planning and delivery capabilities. More than 30 studies were presented during poster or oral sessions at the 57th Annual Meeting of the American Association of Physicists in Medicine held in Anaheim, California July 12 – July 16, 2015.
This week the World Health Organization released its newly updated 4th WHO Model List of Essential Medicines for Children, in which three treatments developed by the Drugs for Neglected Diseases initiative and its partners have now been included.
A new study by researchers at NYU Langone Medical Center and colleagues found that traditional risk factors for stroke - such as high cholesterol - are not as accurate at predicting risk in postmenopausal women as previously thought. Instead, researchers say doctors should refocus their attention on triglyceride levels to determine which women are at highest risk of suffering a devastating and potentially fatal cardiovascular event.
Anadys Pharmaceuticals, Inc. announced today the pricing of its underwritten public offering of 13,888,889 shares of its common stock at a price to the public of $1.80 per share. The gross proceeds to Anadys from this offering are expected to be approximately $25.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses.
Approval by the Obama administration was expected after it gave its initial go-ahead just hours before Florida Gov. Rick Scott announced his support for the health law's Medicaid expansion.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yulia Khan, MD 740 E Highland Ave Ste 101, Phoenix, AZ 85014-3609 Ph: (602) 264-9044 | Yulia Khan, MD 740 E Highland Ave Ste 101, Phoenix, AZ 85014-3609 Ph: (602) 264-9044 |
News Archive
Accuray Incorporated announced today that studies on the clinical use of the TomoTherapy System continue to demonstrate its mainstream use and the benefits of its gold-standard treatment planning and delivery capabilities. More than 30 studies were presented during poster or oral sessions at the 57th Annual Meeting of the American Association of Physicists in Medicine held in Anaheim, California July 12 – July 16, 2015.
This week the World Health Organization released its newly updated 4th WHO Model List of Essential Medicines for Children, in which three treatments developed by the Drugs for Neglected Diseases initiative and its partners have now been included.
A new study by researchers at NYU Langone Medical Center and colleagues found that traditional risk factors for stroke - such as high cholesterol - are not as accurate at predicting risk in postmenopausal women as previously thought. Instead, researchers say doctors should refocus their attention on triglyceride levels to determine which women are at highest risk of suffering a devastating and potentially fatal cardiovascular event.
Anadys Pharmaceuticals, Inc. announced today the pricing of its underwritten public offering of 13,888,889 shares of its common stock at a price to the public of $1.80 per share. The gross proceeds to Anadys from this offering are expected to be approximately $25.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses.
Approval by the Obama administration was expected after it gave its initial go-ahead just hours before Florida Gov. Rick Scott announced his support for the health law's Medicaid expansion.
› Verified 1 days ago
Dr. Stella Xiang Chen, MD Dermatology Medicare: Medicare Enrolled Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
Christopher Bengson, M.D., M.H.S. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4212 N 16th St, Phoenix, AZ 85016 Phone: 602-263-1200 Fax: 602-200-5383 | |
Dr. Karen Taraszka Hastings, MD, PHD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 650 E Indian School Rd, Dermatology Clinic/copper Clinic, Phoenix, AZ 85012 Phone: 602-277-5551 | |
Dr. David Israel Andrews, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1919 E Thomas Rd, Phoenix, AZ 85016 Phone: 602-933-0895 Fax: 602-933-2436 | |
Richard George Bottiglione, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4045 E Bell Rd, 125, Phoenix, AZ 85032 Phone: 602-971-0268 Fax: 602-971-1556 | |
Amanda Carroll Rainwater, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 11130 N Tatum Blvd, #100, Phoenix, AZ 85028 Phone: 602-494-1817 Fax: 602-494-7103 | |
Dr. Kenneth Stephen Bistricky, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 650 E Indian School Rd, Phoenix, AZ 85012 Phone: 602-277-5551 |